Chloé Journo

8PUBLICATIONS
18CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Innate immunityMedical infection agents (incl. prions)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 25, 2026
A multi-omics approach reveals specific oncogenic and inflammatory potential of viral oncoproteins Tax from neglected HTLV-1b and -1c genotypes.

|Jul 07, 2025
Untangling the causes of geographical disparities in the clinical outcome of HTLV-1 infection: a critical perspective on the contribution of viral genetic diversity.

Thomas Duchateau, Philippe V Afonso, Chloé Journo

|Jul 27, 2022
Is the HTLV-1 Retrovirus Targeted by Host Restriction Factors?

Auriane Carcone, Chloé Journo, Hélène Dutartre

|Apr 09, 2022
A novel domain within the CIL regulates egress of IFITM3 from the Golgi and reveals a regulatory role of IFITM3 on the secretory pathway.

Li Zhong, Yuxin Song, Federico Marziali

|Nov 17, 2021
Nipah virus W protein harnesses nuclear 14-3-3 to inhibit NF-κB-induced proinflammatory response.

François Enchéry, Claire Dumont, Mathieu Iampietro

|Aug 28, 2021
HTLV-1 Disease.

Chloé Journo, Fabiola Martin

Pageof 2

Frequent Collaborators

2 joint publications

Andrea Cimarelli

2 joint publications

Hélène Dutartre

1 joint publications

Henri Gruffat

1 joint publications

Frédéric Catez